Merck Investor Relations Material
Latest events
Q3 2024
Merck
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Merck KGaA
Access all reports
Segment Data
Access more data
Net sales by
Business area
Life Science
Healthcare
Electronics
Expenses by
Financials
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. The company's Life Science business segment focuses on the development, manufacture, marketing and distribution of pharmaceutical products. It offers drugs for a range of therapeutic indications from central nervous system diseases to cardiovascular and metabolic disorders. In addition to its own pharmaceutical activities, MERCK helps develop medicines for customers. The company also participates in the development of active substances with partners.
Key slides for Merck KGaA
CMD 2024
Merck KGaA
CMD 2024
Merck KGaA
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
MRK
Country
🇩🇪 Germany